Lilly acquires InduPro
Lilly agreed to acquire InduPro. Reported deal value: $950M. Status: Announced. Sector: biotech. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
Lilly links up with InduPro in next- gen cancer treatment deal worth up to $ 950M By Jan 7, 2026 3:52pm Eli Lilly biotech deal s Sanofi ADCs Shortly after securing a partnership with Sanofi, InduPro is linking up with Eli Lilly in efforts to discover new cancer treatment s via a pact that could be worth up to $950 million
Deal timeline
This transaction is classified in biotech with a reported deal value of $950M. Figures and status may change as sources update.